Dr. Serena Koenig is an Associate Physician in the Division of Global Health Equity and the Division of Infectious Diseases at Brigham and Women’s Hospital and Associate Professor of Medicine at Harvard Medical School. She has been working in Haiti for over 15 years, conducting clinical research and providing care for patients with HIV and/or TB.
Dr. Koenig collaborates closely with the Haitian Group for the Study of Kaposi’s Sarcoma and Opportunistic Infections (GHESKIO) in Port-au-Prince. GHESKIO is the largest provider of HIV and TB care in the Americas, and an internationally renowned research center. Dr. Koenig serves as a senior advisor in GHESKIO’s Clinical Trials Unit. She works with her Haitian colleagues to identify and evaluate new interventions to improve outcomes for HIV and TB.
She is currently the co-primary investigator for PRESCIENT, a clinical trial evaluating the efficacy of a novel 12-week regimen for the treatment of drug-susceptible TB, which is being conducted in Haiti and South Africa. She is also the co-primary investigator for a clinical trial assessing the efficacy of a bictegravir-based regimen for second-line HIV treatment, as well as three other studies which are evaluating different strategies to optimize the delivery of care for HIV. Dr. Koenig and her GHESKIO colleagues have also conducted two randomized trials of same-day HIV treatment initiation, which have impacted international treatment guidelines for HIV.
She has authored or co-authored nearly 100 manuscripts and book chapters related to the treatment of HIV and/or TB.
Dr. Koenig received her MD with Honors from the University of Washington and completed her residency at Brigham and Women’s Hospital and her infectious disease fellowship at Brigham and Women’s and Massachusetts General Hospitals. She completed her Masters in Public Health at the Harvard School of Public Health.
